GIP
PETX

Granite Investment Partners’s Aratana Therapeutics, Inc. PETX Stock Holding History

Granite Investment Partners’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-39,997
Closed -$245K – 381
2018
Q4 		$245K Hold
39,997
– – 0.02% 308
2018
Q3 		$234K Hold
39,997
– – 0.01% 294
2018
Q2 		$170K Hold
39,997
– – 0.01% 302
2018
Q1 		$177K Sell
39,997
-32,656
-45% -$146K 0.01% 288
2017
Q4 		$382K Buy
+72,653
New +$444K 0.02% 277

Other funds holding PETX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Granite Investment Partners's PETX Position: Q1 2019 in Review

Granite Investment Partners sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 39,997 shares — an estimated $245K sold.

Granite Investment Partners first reported a position in PETX in Q4 2017 and held it in 5 quarters. The position peaked at $382K in Q4 2017. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.

  • Granite Investment Partners reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Granite Investment Partners sold 39,997 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $245K.
  • Granite Investment Partners first reported a position in Aratana Therapeutics, Inc. in Q4 2017 and held it in 5 quarters.
  • Granite Investment Partners's Aratana Therapeutics, Inc. position peaked at $382K in Q4 2017.
  • 104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.

Based on Granite Investment Partners's 13F filing for Q1 2019, filed 13 May 2019.